白斑治療の世界市場レポート 2025年

白斑治療市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR5.7％で19億3,000万米ドルに成長します。予測期間の成長は、免疫調節療法の革新、研究資金の増加、皮膚科疾患に対する世界の保健イニシアティブ、併用療法の受け入れ拡大、皮膚科医療インフラの強化などに起因します。予測期間の主な動向には、併用療法、研究開発、患者中心のアプローチ、世界の認識と支持、規制状況などが含まれます。

美容整形や美容施術の需要の増加が白斑治療市場の成長を後押しすると予測されます。美容・美容整形には、顔や体の輪郭、肌の質を改善する方法など、個人の外見を向上させることを目的とした外科的・非外科的治療が含まれます。このような需要の高まりは、美の向上に対する社会的受容の拡大、技術の進歩、セルフケアとウェルネスに対する意識の高まり、ソーシャルメディアとセレブ文化の影響、個人に合わせた非侵襲的な治療オプションの嗜好といった要因に後押しされています。白斑の心理的影響に対する認識が高まるにつれ、より均一な肌色を実現し、全体的な外見を向上させる美容整形を求める患者が増加しています。例えば、2023年3月、美容外科手術の安全性と革新性を促進することを目的とした英国を拠点とする団体である英国美容整形外科医協会（British Association of Aesthetic Plastic Surgeons）は、2022年に行われた美容整形手術の件数は31,057件で、前年から102％増加したと報告しました。2022年の美容整形手術のうち、女性が占める割合は93％で、2021年から101％増加した一方、男性が占める割合は7％で、前年から118％の大幅な増加を示しました。このように、美容整形や美容施術に対する需要の高まりが白斑治療市場を牽引しています。

白斑治療市場の一般的な動向は、製品のイノベーションに重点を置いていることです。この市場に参入している企業は、市場での確固たる地位を維持するための戦略の一環として、斬新な製品の導入に力を注いでいます。例えば、2022年7月、米国の製薬会社Incyte Corporationは、12歳以上の成人および小児患者における非分節性白斑の局所治療薬として、OpzeluraTM（ルキソリチニブ）クリーム1.5%をFDAに承認されたと発表しました。オプセルラは、非分節性白斑患者の体表面積の10%までの患部に1日2回外用するよう設計されています。オプセルーラを使用した患者は、24週目に顔面白斑面積得点指数（F-VASI75）においてベースラインから75％の改善を一貫して示しました。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界白斑治療PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の白斑治療市場：成長率分析
• 世界の白斑治療市場の実績：規模と成長, 2019-2024
• 世界の白斑治療市場の予測：規模と成長, 2024-2029, 2034F
• 世界白斑治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の白斑治療市場薬物による、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗ヒスタミン薬
• H2拮抗薬
• 三環系抗うつ薬
• その他の薬物
• 世界の白斑治療市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 急性蕁麻疹
• 慢性蕁麻疹
• 世界の白斑治療市場投与方法別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 注射可能
• オーラル
• その他の投与方法
• 世界の白斑治療市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• オンライン薬局
• 世界の白斑治療市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• ホームケア
• 専門クリニック
• その他のエンドユーザー
• 世界の白斑治療市場抗ヒスタミン薬の種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• セチリジン
• ロラタジン
• ジフェンヒドラミン
• 世界の白斑治療市場、H2拮抗薬のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ラニチジン
• ファモチジン
• シメチジン
• 世界の白斑治療市場三環系抗うつ薬の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• アミトリプチリン
• ノルトリプチリン
• ドキセピン
• 世界の白斑治療市場、その他の医薬品のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• コルチコステロイド
• 免疫調節薬
• 光線療法剤

第7章 地域別・国別分析

• 世界の白斑治療市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の白斑治療市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 白斑治療市場：競合情勢
• 白斑治療市場：企業プロファイル
  • Clinuvel Pharmaceuticals Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Dr. Reddy's Laboratories Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Incyte Corporation Overview, Products and Services, Strategy and Financial Analysis
  • STRATA Skin Sciences Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Astellas Pharma Inc.
• Bausch Health Companies Inc.
• Arcutis Biotherapeutics
• Strides Pharma Science Limited
• Mylan N.V.
• Glenmark Pharmaceuticals Ltd.
• Clarify Medical Inc.
• Novartis AG
• LEO Pharma A/S
• Dermfix Ltd
• Bristol-Myers Squibb
• Dermavant Science Inc.
• Merck KGaA
• Celgene
• Boston Pharmaceuticals

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 白斑治療市場2029：新たな機会を提供する国
• 白斑治療市場2029：新たな機会を提供するセグメント
• 白斑治療市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Vitiligo treatment addresses a chronic autoimmune condition characterized by the loss of pigmentation or color in specific skin regions. These treatments play a crucial role in both halting and reversing the progression of vitiligo.

The primary classes of drugs used in vitiligo treatment include antihistamines, h2 antagonists, tricyclic antidepressants, and others. Antihistamines, which inhibit histamine in the body, are employed to manage reactions to allergens and can also be beneficial in reducing histamine levels in individuals with vitiligo. Treatment options encompass acute urticaria and chronic urticaria, with various administration methods available, including injectable, oral, and others. These treatments are accessible through diverse distribution channels such as hospital pharmacies, retail pharmacies, and online pharmacies. They are utilized by a range of end-users, including hospitals, homecare services, specialty clinics, and others.

The vitiligo treatment market size has grown strongly in recent years. It will grow from $1.49 billion in 2023 to $1.59 billion in 2024 at a compound annual growth rate (CAGR) of 6.5%. The rise observed in the historical period can be ascribed to a higher incidence of vitiligo, advancements in dermatology research, enhanced patient awareness, a variety of treatment modalities, and a patient-centric approach in healthcare.

The vitiligo treatment market size has grown steadily in recent years. It will grow from$1.47 billion in 2024 to $1.54 billion in 2025 at a compound annual growth rate (CAGR) of 4.6%. The growth in the historic period can be attributed to increased prevalence of vitiligo, advancements in dermatology research, improving patient awareness, diverse treatment modalities, patient-centric approach in healthcare

The vitiligo treatment market size is expected to see strong growth in the next few years. It will grow to $1.93 billion in 2029 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to innovations in immunomodulatory therapies, increasing research funding, global health initiatives for dermatological conditions, growing acceptance of combination therapies, enhanced dermatology care infrastructure. Major trends in the forecast period include combination therapies, research and development, patient-centric approaches, global awareness and advocacy, regulatory landscape.

The increasing demand for cosmetic and aesthetic procedures is anticipated to boost the growth of the vitiligo treatment market. Cosmetic and aesthetic procedures encompass a variety of surgical and non-surgical treatments aimed at enhancing an individual's appearance, including methods to improve facial features, body contours, and skin quality. This rising demand is fueled by factors such as greater societal acceptance of beauty enhancements, technological advancements, heightened awareness of self-care and wellness, the influence of social media and celebrity culture, and a preference for personalized, non-invasive treatment options. As awareness of the psychological effects of vitiligo grows, more patients are seeking cosmetic procedures to achieve a more uniform skin tone and enhance their overall appearance. For example, in March 2023, the British Association of Aesthetic Plastic Surgeons, a UK-based organization dedicated to promoting safety and innovation in cosmetic surgery, reported that there were 31,057 cosmetic procedures performed in 2022, a 102% increase from the previous year. In 2022, women accounted for 93% of all cosmetic procedures, reflecting a 101% rise from 2021, while men represented 7% of the procedures, showing a significant increase of 118% from the prior year. Thus, the growing demand for cosmetic and aesthetic procedures is driving the vitiligo treatment market.

A prevailing trend in the vitiligo treatment market is the emphasis on product innovations. Companies engaged in this market are dedicated to introducing novel products as part of their strategy to maintain a strong market position. For instance, in July 2022, Incyte Corporation, a pharmaceutical firm based in the United States, announced the FDA's approval of OpzeluraTM (ruxolitinib) cream 1.5% for the topical treatment of non-segmental vitiligo in both adult and pediatric patients aged 12 years and older. Opzelura is designed for twice-daily topical application to affected areas covering up to 10% of the body surface area in individuals with non-segmental vitiligo. Patients using Opzelura consistently demonstrated a 75% improvement from baseline in the Face Vitiligo Area Scoring Index (F-VASI75) at Week 24.

Major companies in the vitiligo treatment market are focusing on developing innovative products, including advanced topical therapies aimed at improving skin repigmentation and enhancing the quality of life for individuals affected by this chronic condition. Advanced topical therapy represents a state-of-the-art treatment that targets the underlying inflammatory processes linked to vitiligo, promoting skin color restoration through effective mechanisms. For example, in July 2022, Incyte, a US-based biopharmaceutical company, announced the U.S. FDA's approval of Opzelura (ruxolitinib) cream for treating vitiligo. Opzelura is a topical Janus kinase (JAK) inhibitor that modulates the inflammatory response, facilitating repigmentation in affected areas. By providing a non-invasive treatment option, Opzelura addresses unmet needs in the vitiligo market, empowering patients with effective management solutions and improving their overall quality of life.

In October 2022, Incyte Corp., a U.S.-based pharmaceutical company, completed the acquisition of Villaris Therapeutics Inc. for an undisclosed amount. This strategic move expanded Incyte's existing portfolio and significantly enhanced treatment options for vitiligo patients, leveraging the acquired knowledge. Villaris Therapeutics Inc. is a biopharmaceutical firm based in the United States, specializing in the development of novel treatments for individuals with vitiligo.

Major companies operating in the vitiligo treatment market include Cliniuvel Pharmaceuticals Ltd., Dr. Reddy's Laboratories Ltd., Pfizer Inc., Incyte Corporation, STRATA Skin Sciences, Astellas Pharma Inc., Bausch Health Companies Inc., Arcutis Biotherapeutics, Strides Pharma Science Limited, Mylan N.V., Glenmark Pharmaceuticals Ltd., Clarify Medical Inc., Novartis AG, LEO Pharma A/S, Dermfix Ltd, Bristol-Myers Squibb, Dermavant Science Inc., Merck KGaA, Celgene, Boston Pharmaceuticals, DermTech, Galderma S.A., Allergan Inc., Amgen, Koninklijke Philips N.V., Sun Pharmaceutical Industries Ltd., Thermo Fisher Scientific Inc., Vitiligo Research Foundation, Vitiligo Bond Inc., Vitiligo Society, Vitiligo Clinic and Research Center, Vitiligo Support International

North America was the largest region in the global vitiligo treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vitiligo treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the vitiligo treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The vitiligo treatment market consists of revenues earned by entities by providing moderate-to-high strength topical corticosteroids, calcineurin inhibitors, and drugs including Ruxolitinib. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Vitiligo Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on vitiligo treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for vitiligo treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The vitiligo treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Drugs: Antihistamines; H2 Antagonists; Tricyclic Antidepressants; Other Drugs
• 2) By Types: Acute Urticaria; Chronic Urticaria
• 3) By Mode Of Administration: Injectable; Oral; Other Modes Of Administration
• 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• 5) By End-User: Hospitals; Homecare; Specialty Clinics; Other End-Users
• Subsegments:
• 1) By Antihistamines: Cetirizine; Loratadine; Diphenhydramine
• 2) By H2 Antagonists: Ranitidine; Famotidine; Cimetidine
• 3) By Tricyclic Antidepressants: Amitriptyline; Nortriptyline; Doxepin
• 4) By Other Drugs: Corticosteroids; Immunomodulators; Phototherapy Agents
• Companies Mentioned: Cliniuvel Pharmaceuticals Ltd.; Dr. Reddy's Laboratories Ltd.; Pfizer Inc.; Incyte Corporation; STRATA Skin Sciences
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Vitiligo Treatment Market Characteristics

3. Vitiligo Treatment Market Trends And Strategies

4. Vitiligo Treatment Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Vitiligo Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Vitiligo Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Vitiligo Treatment Market Growth Rate Analysis
• 5.4. Global Vitiligo Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Vitiligo Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Vitiligo Treatment Total Addressable Market (TAM)

6. Vitiligo Treatment Market Segmentation

• 6.1. Global Vitiligo Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antihistamines
• H2 Antagonists
• Tricyclic Antidepressants
• Other Drugs
• 6.2. Global Vitiligo Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Acute Urticaria
• Chronic Urticaria
• 6.3. Global Vitiligo Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Injectable
• Oral
• Other Modes Of Administration
• 6.4. Global Vitiligo Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• 6.5. Global Vitiligo Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Homecare
• Specialty Clinics
• Other End-Users
• 6.6. Global Vitiligo Treatment Market, Sub-Segmentation Of Antihistamines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cetirizine
• Loratadine
• Diphenhydramine
• 6.7. Global Vitiligo Treatment Market, Sub-Segmentation Of H2 Antagonists, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ranitidine
• Famotidine
• Cimetidine
• 6.8. Global Vitiligo Treatment Market, Sub-Segmentation Of Tricyclic Antidepressants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Amitriptyline
• Nortriptyline
• Doxepin
• 6.9. Global Vitiligo Treatment Market, Sub-Segmentation Of Other Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Corticosteroids
• Immunomodulators
• Phototherapy Agents

7. Vitiligo Treatment Market Regional And Country Analysis

• 7.1. Global Vitiligo Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Vitiligo Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Vitiligo Treatment Market

• 8.1. Asia-Pacific Vitiligo Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Vitiligo Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Vitiligo Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Vitiligo Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Vitiligo Treatment Market

• 9.1. China Vitiligo Treatment Market Overview
• 9.2. China Vitiligo Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Vitiligo Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Vitiligo Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Vitiligo Treatment Market

• 10.1. India Vitiligo Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Vitiligo Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Vitiligo Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Vitiligo Treatment Market

• 11.1. Japan Vitiligo Treatment Market Overview
• 11.2. Japan Vitiligo Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Vitiligo Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Vitiligo Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Vitiligo Treatment Market

• 12.1. Australia Vitiligo Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Vitiligo Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Vitiligo Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Vitiligo Treatment Market

• 13.1. Indonesia Vitiligo Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Vitiligo Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Vitiligo Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Vitiligo Treatment Market

• 14.1. South Korea Vitiligo Treatment Market Overview
• 14.2. South Korea Vitiligo Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Vitiligo Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Vitiligo Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Vitiligo Treatment Market

• 15.1. Western Europe Vitiligo Treatment Market Overview
• 15.2. Western Europe Vitiligo Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Vitiligo Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Vitiligo Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Vitiligo Treatment Market

• 16.1. UK Vitiligo Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Vitiligo Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Vitiligo Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Vitiligo Treatment Market

• 17.1. Germany Vitiligo Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Vitiligo Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Vitiligo Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Vitiligo Treatment Market

• 18.1. France Vitiligo Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Vitiligo Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Vitiligo Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Vitiligo Treatment Market

• 19.1. Italy Vitiligo Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Vitiligo Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Vitiligo Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Vitiligo Treatment Market

• 20.1. Spain Vitiligo Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Vitiligo Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Vitiligo Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Vitiligo Treatment Market

• 21.1. Eastern Europe Vitiligo Treatment Market Overview
• 21.2. Eastern Europe Vitiligo Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Vitiligo Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Vitiligo Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Vitiligo Treatment Market

• 22.1. Russia Vitiligo Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Vitiligo Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Vitiligo Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Vitiligo Treatment Market

• 23.1. North America Vitiligo Treatment Market Overview
• 23.2. North America Vitiligo Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Vitiligo Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Vitiligo Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Vitiligo Treatment Market

• 24.1. USA Vitiligo Treatment Market Overview
• 24.2. USA Vitiligo Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Vitiligo Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Vitiligo Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Vitiligo Treatment Market

• 25.1. Canada Vitiligo Treatment Market Overview
• 25.2. Canada Vitiligo Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Vitiligo Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Vitiligo Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Vitiligo Treatment Market

• 26.1. South America Vitiligo Treatment Market Overview
• 26.2. South America Vitiligo Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Vitiligo Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Vitiligo Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Vitiligo Treatment Market

• 27.1. Brazil Vitiligo Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Vitiligo Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Vitiligo Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Vitiligo Treatment Market

• 28.1. Middle East Vitiligo Treatment Market Overview
• 28.2. Middle East Vitiligo Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Vitiligo Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Vitiligo Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Vitiligo Treatment Market

• 29.1. Africa Vitiligo Treatment Market Overview
• 29.2. Africa Vitiligo Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Vitiligo Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Vitiligo Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Vitiligo Treatment Market Competitive Landscape And Company Profiles

• 30.1. Vitiligo Treatment Market Competitive Landscape
• 30.2. Vitiligo Treatment Market Company Profiles
  • 30.2.1. Clinuvel Pharmaceuticals Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Dr. Reddy's Laboratories Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Incyte Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. STRATA Skin Sciences Overview, Products and Services, Strategy and Financial Analysis

31. Vitiligo Treatment Market Other Major And Innovative Companies

• 31.1. Astellas Pharma Inc.
• 31.2. Bausch Health Companies Inc.
• 31.3. Arcutis Biotherapeutics
• 31.4. Strides Pharma Science Limited
• 31.5. Mylan N.V.
• 31.6. Glenmark Pharmaceuticals Ltd.
• 31.7. Clarify Medical Inc.
• 31.8. Novartis AG
• 31.9. LEO Pharma A/S
• 31.10. Dermfix Ltd
• 31.11. Bristol-Myers Squibb
• 31.12. Dermavant Science Inc.
• 31.13. Merck KGaA
• 31.14. Celgene
• 31.15. Boston Pharmaceuticals

32. Global Vitiligo Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Vitiligo Treatment Market

34. Recent Developments In The Vitiligo Treatment Market

35. Vitiligo Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Vitiligo Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Vitiligo Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Vitiligo Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer